Women with and without menopause over age of 40 in Turkey: Consequences and treatment options

Maturitas

Volumn 50, Issue 3, 2005, Pages 167-176

  Biri, Aydan ^a   Bakar, Coskun ^a   Maral, Işil ^a   Karabacak, Onur ^a   Bumin, M Ali ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Complaints; HRT; Knowledge; Menopause

Indexed keywords

ADULT; AGED; ARTICLE; BONE PAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; FAMILY PLANNING; FEMALE; FLUSHING; HEALTH CARE FACILITY; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENOPAUSAL SYNDROME; MENOPAUSE; MYALGIA; NOCTURIA; ORAL CONTRACEPTION; PREMENOPAUSE; QUESTIONNAIRE; RESTLESSNESS; STATISTICAL SIGNIFICANCE; SWEATING; TACHYCARDIA; TURKEY (REPUBLIC);

EID: 14044279156     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.05.013     Document Type: Article

References (35)

1. United Nations Population Division, World population Prospects: The 2002 Revision Population Database. http://esa.un.org/unpp/index.asp?panel=2.
2. State Institute of Statistics Prime Ministry Republic of Turkey, Census of Population, Social and Economic Characteristics of Population, Turkey, 2000.
3. Alpaslan Z.N., Aǧridaǧ G. The factors effecting menopausal. Health Social Foundation J. 2:1995;21-24
4. Carda S.N., Bilge Ş.A., Öztürk T.N., Oya G., Ece O., Hamiyet B. The menopausal age, related factors and climacteric symptoms in Turkish women. Maturitas. 30:1998;37-40
5. Maral I., Yildirim U., Özkan S., Aycan S. Natural menopausal age and associated factors with age at menopause in women of Ankara Gölbaşi region. Clin Sci Doctor. 4:2001;550-554
6. The World Health Report 2003, Annex Table 1, Basic indicators for all Member States. http://www.who.int/whr/2003/annex/en/.
7. Speroff L, Glass RH, Kase NG. Menopause and the perimenopausal transition. In: Clinical Gynecologic Endocrinology and Infertility. 6th ed. Lippincott, Williams and Wilkins, Baltimore, 1999, p. 643-715.
8. Chim H., Iain Tan B.H., Chun Ang C., Darryl Chew E.M., Seng Chong Y., Mei Saw S. The prevalence of menopausal symptoms in a community in Singapore. Maturitas. 41:2002;275-282
9. Yildirim U., Maral I., Özkan S., Bumin M.A. Menopause-related of post-menopausal women in Ankara Gölba_i district. Health Society. 2:1999;22-25
10. Pan H.-A., Wu M.-H., Hsu C.-C., Yao B.-L., Huang K.-E. The perception of menopause among women in Taiwan. Maturitas. 41:2002;269-274
11. Von Mühlen D.G., Silverstein D.K., Connor E.B. A community-based study of symptoms and estrogen replacement in older women. Maturitas. 22:1995;71-78
12. Obermeyer C.M., Schulein M., Hajji N., Azelmat M. Menopause in Morocco: symptomatology and medical management. Maturitas. 41:1995;87-95
13. Stadberg E., Mattsson L.A., Milson I. Women's attitudes and knowledge about the climacteric period and its treatment: a Swedish population-based study. Maturitas. 27:1997;109-116
14. Rizk Diaa.E.E., Bener A., Ezimokhai M., Hassan M.Y., Micallef R. The age symptomatology of natural menopause among United Arab Emirates women. Maturitas. 29:1998;197-202
15. Million Women Study Collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000, Br J Obstet Gynaecol 109;2002:1319-30.
16. Oddens B.J., Boulet M.J. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance. Obstet Gynecol. 90:1997;269-277
17. Bakken K., Eggen A.E., Lund E. Hormone replacement therapy in Norwegian women 1996-1997. Maturitas. 40:2001;131-141
18. Mueller J.E., Döring A., Heier M., Löwel H. Prevalence and determinants of hormone replacement therapy in German women 1984-1995. Maturitas. 43:2002;95-104
19. Gülerman C, Gökmen O, Çelikkanat H, Möröy P, Alabeyoǧlu L, Doǧanay M, Sener B. Prevalence of hormone replacement therapy in menopausal women, Maturitas 27 (Suppl 1);1997:133.
20. WHO: Research on the menopause in the 1990s,Technical Report Series 866, Geneva, 1996.
21. WHO: Research on the menopause, Technical Report Series 670, Geneva, 1981.
22. Barlow D.H., Samsioe G., van Geelen J.M. A study of European womens' experiences of the problems of urogenital ageing and its management. Maturitas. 27:1997;239-247
23. Ünalan T, Koç I. Family planning. In: Demography and Health Survey Turkey 1998, Ankara, University of Haccettepe, Institute of Population, 1999:45-65.
24. The State of the World's Children 2004, Table 1, Basic indicators. http://www.unicef.org/sowc04/sowc04_tables.html.
25. Amore M, Di Donato P, Papalini A, et al. Psychological status at the menopausal transition: an Italian epidemiological study, Maturitas, in press.
26. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas. 14:1992;127-141
27. Greendale G.A., Lee N.P., Arriola E.R. The menopause. Lancet. 353:1999;571-580
28. Morrison M.F., Katz I.R., Parmelee P., Boyce A.A., TenHave T. Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr Psychiatr. 6:1998;277-284
29. Brynhildsen J.O., Bjors E., Skarsgard C., Hammer M.L. Is hormone replacement therapy: a risk factor for low back pain among postmenopausal women. Spine. 23:1998;809-813
30. Stadberg E., Mattsson L.A., Milson I. Womens attitudes and knowledge about the climacteric period and its treatment: a Swedish population-based study. Maturitas. 27:1997;109-116
31. Rizk Diaa.E.E., Bener A., Ezimokhai M., Hassan M.Y., Micallef R. The age symptomatology of natural menopause among United Arab Emirates women. Maturitas. 29:1998;197-202
32. Oddens B.J., Boulet M.J. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance. Obstet Gynecol. 90:1997;269-277
33. Women health initiative randomize controlled trial: risks and benefits of estrogen plus progestin in healthy postmenopausal women, J Am Med Assoc 288;2002:321-33.
34. Ettinger B., Grady D., Tosteson A.N.A., Presman A., Macer J.L. Effect of the women's health initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol. 102:2003;1225-1232
35. Grady D., Ettinger B., Tosteson A.N.A., Presman A., Macer J.L. Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol. 102:2003;1233-1239